Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia.

Gu TL, Goss VL, Reeves C, Popova L, Nardone J, Macneill J, Walters DK, Wang Y, Rush J, Comb MJ, Druker BJ, Polakiewicz RD.

Blood. 2006 Dec 15;108(13):4202-4. Epub 2006 Aug 31.

2.
3.

Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice.

Agerstam H, Järås M, Andersson A, Johnels P, Hansen N, Lassen C, Rissler M, Gisselsson D, Olofsson T, Richter J, Fan X, Ehinger M, Fioretos T.

Blood. 2010 Sep 23;116(12):2103-11. doi: 10.1182/blood-2009-05-217182. Epub 2010 Jun 16.

4.

Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome.

Li F, Zhai YP, Tang YM, Wang LP, Wan PJ.

Genes Chromosomes Cancer. 2012 Sep;51(9):890-7. doi: 10.1002/gcc.21973. Epub 2012 May 23.

PMID:
22619110
5.

The driver of malignancy in KG-1a leukemic cells, FGFR1OP2-FGFR1, encodes an HSP90 addicted oncoprotein.

Jin Y, Zhen Y, Haugsten EM, Wiedlocha A.

Cell Signal. 2011 Nov;23(11):1758-66. doi: 10.1016/j.cellsig.2011.06.010. Epub 2011 Jun 30.

PMID:
21745565
6.

[FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].

Pébusque MJ, Chaffanet M, Popovici C, Birnbaum D.

Bull Cancer. 2000 Dec;87(12):887-94. Review. French.

7.

The 8p11 myeloproliferative syndrome owing to rare FGFR1OP2-FGFR1 fusion.

Onozawa M, Ohmura K, Ibata M, Iwasaki J, Okada K, Kasahara I, Yamaguchi K, Kubota K, Fujisawa S, Shigematsu A, Endo T, Kondo T, Hashino S, Tanaka J, Matsuno Y, Asaka M, Imamura M.

Eur J Haematol. 2011 Apr;86(4):347-9. doi: 10.1111/j.1600-0609.2010.01568.x. Epub 2011 Feb 18. No abstract available.

PMID:
21198859
8.

Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.

Malli T, Buxhofer-Ausch V, Rammer M, Erdel M, Kranewitter W, Rumpold H, Marschon R, Deutschbauer S, Simonitsch-Klupp I, Valent P, Muellner-Ammer K, Sebesta C, Birkner T, Webersinke G.

Genes Chromosomes Cancer. 2016 Jan;55(1):60-8. doi: 10.1002/gcc.22311. Epub 2015 Sep 22.

PMID:
26391436
9.

Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.

Chase A, Bryant C, Score J, Cross NC.

Haematologica. 2013 Jan;98(1):103-6. doi: 10.3324/haematol.2012.066407. Epub 2012 Aug 8.

10.

Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome.

Grand EK, Grand FH, Chase AJ, Ross FM, Corcoran MM, Oscier DG, Cross NC.

Genes Chromosomes Cancer. 2004 May;40(1):78-83.

PMID:
15034873
11.

Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution.

Patnaik MM, Gangat N, Knudson RA, Keefe JG, Hanson CA, Pardanani A, Ketterling RP, Tefferi A.

Am J Hematol. 2010 Apr;85(4):238-42. doi: 10.1002/ajh.21631.

12.

A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.

Morishige S, Oku E, Takata Y, Kimura Y, Arakawa F, Seki R, Imamura R, Osaki K, Hashiguchi M, Yakushiji K, Mizuno S, Yoshimoto K, Nagafuji K, Ohshima K, Okamura T.

Acta Haematol. 2013;129(2):83-9. doi: 10.1159/000341289. Epub 2012 Nov 17.

PMID:
23171834
13.

A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemia.

Gu TL, Mercher T, Tyner JW, Goss VL, Walters DK, Cornejo MG, Reeves C, Popova L, Lee K, Heinrich MC, Rush J, Daibata M, Miyoshi I, Gilliland DG, Druker BJ, Polakiewicz RD.

Blood. 2007 Jul 1;110(1):323-33. Epub 2007 Mar 14.

14.

Molecular identification of a TPR-FGFR1 fusion transcript in an adult with myeloproliferative neoplasm, T-lymphoblastic lymphoma, and a t(1;8)(q25;p11.2).

Kim SY, Kim JE, Park S, Kim HK.

Cancer Genet. 2014 Jun;207(6):258-62. doi: 10.1016/j.cancergen.2014.05.011. Epub 2014 Jun 7.

PMID:
25037443
15.

8p11 myeloproliferative syndrome: a review.

Jackson CC, Medeiros LJ, Miranda RN.

Hum Pathol. 2010 Apr;41(4):461-76. doi: 10.1016/j.humpath.2009.11.003. Review.

PMID:
20226962
16.

Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases.

Ren M, Qin H, Ren R, Tidwell J, Cowell JK.

Cancer Res. 2011 Dec 1;71(23):7312-22. doi: 10.1158/0008-5472.CAN-11-1109. Epub 2011 Sep 21.

17.

Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes.

Walters DK, Goss VL, Stoffregen EP, Gu TL, Lee K, Nardone J, McGreevey L, Heinrich MC, Deininger MW, Polakiewicz R, Druker BJ.

Leuk Res. 2006 Sep;30(9):1097-104. Epub 2006 Feb 7.

PMID:
16464493
18.

Molecular monitoring of 8p11 myeloproliferative syndrome in an infant.

Zhang WW, Habeebu S, Sheehan AM, Naeem R, Hernandez VS, Dreyer ZE, López-Terrada D.

J Pediatr Hematol Oncol. 2009 Nov;31(11):879-83. doi: 10.1097/MPH.0b013e3181b83fd0.

PMID:
19829149
19.

Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice.

Ren M, Qin H, Wu Q, Savage NM, George TI, Cowell JK.

Int J Cancer. 2016 Aug 15;139(4):836-40. doi: 10.1002/ijc.30100. Epub 2016 May 4.

20.

The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.

Macdonald D, Reiter A, Cross NC.

Acta Haematol. 2002;107(2):101-7. Review.

PMID:
11919391

Supplemental Content

Support Center